3 European Penny Stocks With Market Caps Over €20M To Watch

Simply Wall St

Thu, Jul 24, 2025, 7:05 AM 4 min read

As European markets remain mixed, with the pan-European STOXX Europe 600 Index ending roughly flat amid cautious investor sentiment, attention turns to smaller investment opportunities. Penny stocks, though often considered a niche area of investing, continue to offer intriguing possibilities for those looking beyond established market giants. Despite their historical connotations, penny stocks can still provide a blend of affordability and growth potential when backed by strong financial health.

Click here to see the full list of 338 stocks from our European Penny Stocks screener.

Here’s a peek at a few of the choices from the screener.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Anora Group Oyj is involved in the production, importation, marketing, distribution, and sale of alcoholic beverages across Finland, Europe, and internationally with a market cap of €216.17 million.

Operations: The company’s revenue is derived from three main segments: Wine (€321.4 million), Spirits (€224.9 million), and Industrial (€229.4 million).

Market Cap: €216.17M

Anora Group Oyj, with a market cap of €216.17 million, has recently become profitable but faces challenges in covering its debt and interest payments with operating cash flow and EBIT, respectively. The company’s short-term assets exceed both its short-term and long-term liabilities, indicating liquidity strength. However, the dividend yield of 6.88% is not well supported by earnings or free cash flows. Anora’s stock trades significantly below estimated fair value, suggesting potential undervaluation. Recent management changes include appointing Imre Avalo as Senior Vice President for Spirits, which may influence strategic direction within this segment.

• Click here and access our complete financial health analysis report to understand the dynamics of Anora Group Oyj.

• Gain insights into Anora Group Oyj’s outlook and expected performance with our report on the company’s earnings estimates.

Simply Wall St Financial Health Rating: ★★★★★★